APA (7th ed.) Citation

S, P., T, T., R, W., N, D., FC, L., K, B., . . . CH, S. (2026). Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study. Clinical and translational science, 19(5), e70563. https://doi.org/10.1111/cts.70563

Chicago Style (17th ed.) Citation

S, Pan, et al. "Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study." Clinical and Translational Science 19, no. 5 (2026): e70563. https://doi.org/10.1111/cts.70563.

MLA (9th ed.) Citation

S, Pan, et al. "Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study." Clinical and Translational Science, vol. 19, no. 5, 2026, p. e70563, https://doi.org/10.1111/cts.70563.